BMO Capital analyst John Kim maintained a Hold rating on National Health Investors (NYSE:NHI) on Tuesday, setting a price target of $68, which is approximately 22.61% above the present share price of $55.46.
Kim expects National Health Investors to post earnings per share (EPS) of $0.85 for the fourth quarter of 2021.
The current consensus among 4 TipRanks analysts is for a Hold rating of shares in National Health Investors, with an average price target of $65.67.
The analysts price targets range from a high of $68 to a low of $64.
In its latest earnings report, released on 06/30/2021, the company reported a quarterly revenue of $74.33 million and a net profit of $46.5 million. The company's market cap is $2.54 billion.
According to TipRanks.com, BMO Capital analyst John Kim is currently ranked with 4 stars on a 0-5 stars ranking scale, with an average return of 3.8% and a 55.68% success rate.
National Health Investors, Inc. is a real estate investment trust, which engages in the sale-leaseback, joint-venture, mortgage, and mezzanine financing of senior housing and medical investments. Its portfolio includes lease, mortgage and other note investments in independent living facilities, assisted living facilities, entrance-fee communities, senior living campuses, skilled nursing facilities, specialty hospitals and medical office buildings. The company was founded by W. Andrew Adams in 1991 and is headquartered in Murfreesboro, TN.